Fingerprint
Dive into the research topics of 'EGFR inhibitors as first-line therapy in EGFR mutation-positive patients with NSCLC'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
EGFR inhibitors as first-line therapy in EGFR mutation-positive patients with NSCLC
Kimberly J. Gorden, Parvin Mesbah, Jill M. Kolesar
Research output: Contribution to journal › Review article › peer-review
8
Scopus
citations